Andere talen ODI Pharma AB

Aandelen

ODI

SE0013409760

slotkoers NORDIC GROWTH MARKET Andere beurzen 00:00:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
7,65 ^SEK	+18,60%		+34,21%	+53,00%

02/05	ODI Pharma AB geeft verkooprichtlijnen voor het derde kwartaal van het jaar 2024	CI
22/02	ODI Pharma AB (publ) rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Preliminary results for ODI Pharma indicate significant revenue increase in Q3 2023/2024	02/05
ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024	02/05
ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	22/02
Announcement from the Annual General Meeting in ODI Pharma AB (publ)	15/12
ODI Pharma Sells CBD Skincare Brand for SEK3 Million	06/12
ODI Pharma AB announces sale of the skincare brand kandol. for 3.2 msek	06/12
ODI Pharma AB publishes the annual report for the fiscal year 2022/2023	24/11
ODI Pharma AB Reports Earnings Results for the First Quarter Ended September 30, 2023	24/11
ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023	23/11
Notice to Annual General Meeting in ODI Pharma AB (publ)	13/11
ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023	24-08-23
ODI Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	24-08-23
ODI Pharma’s Stock Soars After Exclusive Supplier Deal With Synoptis Pharma	07-08-23
ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.	07-08-23
ODI Phaa AB Enters into Exclusive Collaboration with Synoptis Pharma Sp. Z o.o	07-08-23
ODI Pharma AB receives loan financing of EUR 350,000	01-06-23
ODI Pharma AB Receives Loan Financing of EUR 350,000	01-06-23
ODI Pharma AB: Publication of interim report report Q3 2022/2023	25-05-23
ODI Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	25-05-23
ODI Pharma AB: Publication of half-year report 2022/2023	23-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ODI Pharma AB

Aandelen

ODI

SE0013409760

Andere talen

Filters